Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 study. - Ndiaye BP; Koech L; Mercer LD; Aponte JJ; Cisse B; Riziki F; Keter W; Eaton N; Diye S; Wade D; Bob NS; Raine MG; et al. (The Lancet. Global health, 2025)